Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Recurrence Patterns After Resection of Colorectal Liver Metastasis are Modified by Perioperative Systemic Chemotherapy.

Buisman FE, Galjart B, van der Stok EP, Balachandran VP, Boerner T, Drebin JA, Grünhagen DJ, Jarnagin WR, Kingham TP, Verhoef C, D'Angelica MI, Groot Koerkamp B.

World J Surg. 2019 Aug 13. doi: 10.1007/s00268-019-05121-9. [Epub ahead of print]

PMID:
31410513
2.

An Exploratory Analysis of Fecal Immunochemical Test Performance for Colorectal Cancer Screening in Nigeria.

Knapp GC, Sharma A, Olopade B, Alatise OI, Olasehinde O, Arije OO, Castle PE, Kingham TP.

World J Surg. 2019 Aug 12. doi: 10.1007/s00268-019-05100-0. [Epub ahead of print]

PMID:
31407091
3.

CT radiomics associations with genotype and stromal content in pancreatic ductal adenocarcinoma.

Attiyeh MA, Chakraborty J, McIntyre CA, Kappagantula R, Chou Y, Askan G, Seier K, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ, Iacobuzio-Donahue CA, Simpson AL, Do RK.

Abdom Radiol (NY). 2019 Sep;44(9):3148-3157. doi: 10.1007/s00261-019-02112-1.

PMID:
31243486
4.

Neutrophil-to-Lymphocyte Ratio as a Predictor of Invasive Carcinoma in Patients With Intraductal Papillary Mucinous Neoplasms of the Pancreas.

McIntyre CA, Pulvirenti A, Lawrence SA, Seier K, Gonen M, Balachandran VP, Kingham TP, DʼAngelica MI, Drebin JA, Jarnagin WR, Allen PJ.

Pancreas. 2019 Jul;48(6):832-836. doi: 10.1097/MPA.0000000000001342.

PMID:
31210665
5.

Is Colorectal Cancer Screening Appropriate in Nigeria?

Knapp GC, Alatise OI, Olasehinde OO, Adeyeye A, Ayandipo OO, Weiser MR, Kingham TP.

J Glob Oncol. 2019 Jun;5:1-10. doi: 10.1200/JGO.19.00035.

6.

Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study.

Deng L, Ismond K, Liu Z, Constable J, Wang H, Alatise OI, Weiser MR, Kingham TP, Chang D.

Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1283-1291. doi: 10.1158/1055-9965.EPI-18-1291. Epub 2019 May 31.

PMID:
31151939
7.

Life Without a Breast: Exploring the Experiences of Young Nigerian Women After Mastectomy for Breast Cancer.

Olasehinde O, Arije O, Wuraola FO, Samson M, Olajide O, Alabi T, Arowolo O, Boutin-Foster C, Alatise OI, Kingham TP.

J Glob Oncol. 2019 May;5:1-6. doi: 10.1200/JGO.18.00248.

8.

Evolution of surgical management of gallbladder carcinoma and impact on outcome: results from two decades at a single-institution.

Creasy JM, Goldman DA, Gonen M, Dudeja V, O'Reilly EM, Abou-Alfa GK, Cercek A, Harding JJ, Balachandran VP, Drebin JA, Allen PJ, Kingham TP, D'Angelica MI, Jarnagin WR.

HPB (Oxford). 2019 Apr 23. pii: S1365-182X(19)30496-4. doi: 10.1016/j.hpb.2019.03.370. [Epub ahead of print]

PMID:
31027875
9.

ASO Author Reflections: Perioperative Genomic Profiles and Prognosis of Peripheral and Perihepatic Circulating Tumor DNA in Patients with Colorectal Liver Metastases.

Narayan RR, Kingham TP.

Ann Surg Oncol. 2019 Apr 15. doi: 10.1245/s10434-019-07360-5. [Epub ahead of print] No abstract available.

PMID:
30989499
10.

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.

Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B.

BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6.

11.

Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.

Gholami S, Kemeny NE, Boucher TM, Gönen M, Cercek A, Kingham TP, Balachandran V, Allen P, DeMatteo R, Drebin J, Jarnagin W, D'Angelica M.

Ann Surg. 2019 Feb 19. doi: 10.1097/SLA.0000000000003248. [Epub ahead of print]

PMID:
30817353
12.

Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer.

Narayan RR, Goldman DA, Gonen M, Reichel J, Huberman KH, Raj S, Viale A, Kemeny NE, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Jarnagin WR, Kingham TP.

Ann Surg Oncol. 2019 Jun;26(6):1824-1832. doi: 10.1245/s10434-019-07201-5. Epub 2019 Jan 31.

PMID:
30706231
13.

Utility of Image Guidance in the Localization of Disappearing Colorectal Liver Metastases.

Pak LM, Gagnière J, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Miga MI, Simpson AL, Kingham TP.

J Gastrointest Surg. 2019 Apr;23(4):760-767. doi: 10.1007/s11605-019-04106-2. Epub 2019 Jan 24.

PMID:
30680630
14.

Perioperative Bundle to Reduce Surgical Site Infection after Pancreaticoduodenectomy: A Prospective Cohort Study.

Lawrence SA, McIntyre CA, Pulvirenti A, Seier K, Chou Y, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Drebin JA, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Apr;228(4):595-601. doi: 10.1016/j.jamcollsurg.2018.12.018. Epub 2019 Jan 8.

PMID:
30630087
15.

Barriers to mammography screening in Nigeria: A survey of two communities with different access to screening facilities.

Olasehinde O, Alatise OI, Arowolo OA, Mango VL, Olajide OS, Omisore AD, Boutin-Foster C, Kingham TP.

Eur J Cancer Care (Engl). 2019 Mar;28(2):e12986. doi: 10.1111/ecc.12986. Epub 2019 Jan 6.

PMID:
30614109
16.

Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.

Narayan RR, Creasy JM, Goldman DA, Gönen M, Kandoth C, Kundra R, Solit DB, Askan G, Klimstra DS, Basturk O, Allen PJ, Balachandran VP, D'Angelica MI, DeMatteo RP, Drebin JA, Kingham TP, Simpson AL, Abou-Alfa GK, Harding JJ, O'Reilly EM, Butte JM, Matsuyama R, Endo I, Jarnagin WR.

Cancer. 2019 Feb 15;125(4):575-585. doi: 10.1002/cncr.31850. Epub 2018 Nov 14.

PMID:
30427539
17.

Minimally Invasive Staging Surgery for Cancer.

Cohen NA, Kingham TP.

Surg Oncol Clin N Am. 2019 Jan;28(1):61-77. doi: 10.1016/j.soc.2018.07.006. Epub 2018 Oct 23. Review.

PMID:
30414682
18.

Outcomes after Pancreatectomy with Routine Pasireotide Use.

Kunstman JW, Goldman DA, Gönen M, Balachandran VP, D'Angelica MI, Kingham TP, Jarnagin WR, Allen PJ.

J Am Coll Surg. 2019 Feb;228(2):161-170.e2. doi: 10.1016/j.jamcollsurg.2018.10.018. Epub 2018 Nov 7.

PMID:
30414453
19.

Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):395. doi: 10.1007/s00268-018-4845-x.

PMID:
30406321
20.

Prospective Genotyping of Hepatocellular Carcinoma: Clinical Implications of Next-Generation Sequencing for Matching Patients to Targeted and Immune Therapies.

Harding JJ, Nandakumar S, Armenia J, Khalil DN, Albano M, Ly M, Shia J, Hechtman JF, Kundra R, El Dika I, Do RK, Sun Y, Kingham TP, D'Angelica MI, Berger MF, Hyman DM, Jarnagin W, Klimstra DS, Janjigian YY, Solit DB, Schultz N, Abou-Alfa GK.

Clin Cancer Res. 2019 Apr 1;25(7):2116-2126. doi: 10.1158/1078-0432.CCR-18-2293. Epub 2018 Oct 29.

PMID:
30373752
21.

Robotic Versus Open Minor Liver Resections of the Posterosuperior Segments: A Multinational, Propensity Score-Matched Study.

Nota CL, Woo Y, Raoof M, Boerner T, Molenaar IQ, Choi GH, Kingham TP, Latorre K, Borel Rinkes IHM, Hagendoorn J, Fong Y.

Ann Surg Oncol. 2019 Feb;26(2):583-590. doi: 10.1245/s10434-018-6928-1. Epub 2018 Oct 17.

PMID:
30334196
22.

Endoscopic versus percutaneous drainage of post-operative peripancreatic fluid collections following pancreatic resection.

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Covey AM, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Gerdes H, Allen PJ, Schattner MA.

HPB (Oxford). 2019 Apr;21(4):434-443. doi: 10.1016/j.hpb.2018.08.010. Epub 2018 Oct 4.

PMID:
30293867
23.

Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.

Olasehinde O, Alatise O, Arowolo O, Adisa A, Wuraola F, Boutin-Foster C, Lawal O, Kingham T.

J Surg Oncol. 2018 Nov;118(6):861-866. doi: 10.1002/jso.25215. Epub 2018 Oct 7.

PMID:
30293243
24.

A preoperative prognostic model to predict surgical success in patients with perihilar cholangiocarcinoma.

Gaspersz MP, Buettner S, Roos E, van Vugt JLA, Coelen RJS, Vugts J, Wiggers JK, Allen PJ, Besselink MG, Busch ORC, Belt EJ, D'Angelica MI, DeMatteo RP, de Jonge J, Kingham TP, Polak WG, Willemssen FEJA, van Gulik TM, Jarnagin WR, Ijzermans JNM, Groot Koerkamp B.

J Surg Oncol. 2018 Sep;118(3):469-476. doi: 10.1002/jso.25174. Epub 2018 Aug 21.

PMID:
30132904
25.

Preoperative risk prediction for intraductal papillary mucinous neoplasms by quantitative CT image analysis.

Attiyeh MA, Chakraborty J, Gazit L, Langdon-Embry L, Gonen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Do RK, Simpson AL.

HPB (Oxford). 2019 Feb;21(2):212-218. doi: 10.1016/j.hpb.2018.07.016. Epub 2018 Aug 7.

PMID:
30097414
26.

Surgical oncology at a major referral center in Ghana: Burden, staging, and outcomes.

Gyedu A, Gaskill CE, Agbedinu K, Salazar DR, Kingham TP.

J Surg Oncol. 2018 Sep;118(3):581-587. doi: 10.1002/jso.25168. Epub 2018 Aug 10.

PMID:
30095201
27.

Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.

Zheng J, Sadot E, Vigidal JA, Klimstra DS, Balachandran VP, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Ventura A.

PLoS One. 2018 Jul 27;13(7):e0200776. doi: 10.1371/journal.pone.0200776. eCollection 2018.

28.

Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.

Gagnière J, Dupré A, Gholami SS, Pezet D, Boerner T, Gönen M, Kingham TP, Allen PJ, Balachandran VP, De Matteo RP, Drebin JA, Yaeger R, Kemeny NE, Jarnagin WR, D'Angelica MI.

Ann Surg. 2018 Jul 10. doi: 10.1097/SLA.0000000000002968. [Epub ahead of print]

PMID:
29995686
29.

Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients.

Sadot E, Zheng J, Srouji R, Strong VE, Gönen M, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Fong Y, Weiser MR, Jarnagin WR.

World J Surg. 2019 Feb;43(2):385-394. doi: 10.1007/s00268-018-4726-3. Erratum in: World J Surg. 2018 Nov 7;:.

PMID:
29955938
30.

Quantitative imaging features of pretreatment CT predict volumetric response to chemotherapy in patients with colorectal liver metastases.

Creasy JM, Midya A, Chakraborty J, Adams LB, Gomes C, Gonen M, Seastedt KP, Sutton EJ, Cercek A, Kemeny NE, Shia J, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI, Do RKG, Simpson AL.

Eur Radiol. 2019 Jan;29(1):458-467. doi: 10.1007/s00330-018-5542-8. Epub 2018 Jun 19.

PMID:
29922934
31.

Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.

Margonis GA, Sasaki K, Gholami S, Kim Y, Andreatos N, Rezaee N, Deshwar A, Buettner S, Allen PJ, Kingham TP, Pawlik TM, He J, Cameron JL, Jarnagin WR, Wolfgang CL, D'Angelica MI, Weiss MJ.

Br J Surg. 2018 Aug;105(9):1210-1220. doi: 10.1002/bjs.10838. Epub 2018 Apr 25.

PMID:
29691844
32.

A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.

Alatise OI, Ayandipo OO, Adeyeye A, Seier K, Komolafe AO, Bojuwoye MO, Afuwape OO, Zauber A, Omisore A, Olatoke S, Akere A, Famurewa O, Gonen M, Irabor DO, Kingham TP.

Cancer. 2018 Jul 1;124(13):2766-2773. doi: 10.1002/cncr.31399. Epub 2018 Apr 12.

33.

Preoperative Risk Score to Predict Occult Metastatic or Locally Advanced Disease in Patients with Resectable Perihilar Cholangiocarcinoma on Imaging.

Wiggers JK, Groot Koerkamp B, van Klaveren D, Coelen RJ, Nio CY, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Gulik TM, Jarnagin WR.

J Am Coll Surg. 2018 Aug;227(2):238-246.e2. doi: 10.1016/j.jamcollsurg.2018.03.041. Epub 2018 Apr 6.

34.

Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN).

Al Efishat M, Attiyeh MA, Eaton AA, Gönen M, Basturk O, Klimstra D, D'Angelica MI, DeMatteo RP, Kingham TP, Balachandran V, Jarnagin WR, Allen PJ.

Ann Surg Oncol. 2018 Jun;25(6):1752-1759. doi: 10.1245/s10434-018-6445-2. Epub 2018 Mar 27.

PMID:
29589164
35.

Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?

Creasy JM, Sadot E, Koerkamp BG, Chou JF, Gonen M, Kemeny NE, Balachandran VP, Kingham TP, DeMatteo RP, Allen PJ, Blumgart LH, Jarnagin WR, D'Angelica MI.

Surgery. 2018 Jun;163(6):1238-1244. doi: 10.1016/j.surg.2018.01.004. Epub 2018 Feb 15.

PMID:
29455841
36.

Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis.

Attiyeh MA, Chakraborty J, Doussot A, Langdon-Embry L, Mainarich S, Gönen M, Balachandran VP, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Allen PJ, Simpson AL, Do RK.

Ann Surg Oncol. 2018 Apr;25(4):1034-1042. doi: 10.1245/s10434-017-6323-3. Epub 2018 Jan 29.

PMID:
29380093
37.

Extracellular matrix proteins and carcinoembryonic antigen-related cell adhesion molecules characterize pancreatic duct fluid exosomes in patients with pancreatic cancer.

Zheng J, Hernandez JM, Doussot A, Bojmar L, Zambirinis CP, Costa-Silva B, van Beek EJAH, Mark MT, Molina H, Askan G, Basturk O, Gonen M, Kingham TP, Allen PJ, D'Angelica MI, DeMatteo RP, Lyden D, Jarnagin WR.

HPB (Oxford). 2018 Jul;20(7):597-604. doi: 10.1016/j.hpb.2017.12.010. Epub 2018 Jan 12.

38.

Characterization and correction of intraoperative soft tissue deformation in image-guided laparoscopic liver surgery.

Heiselman JS, Clements LW, Collins JA, Weis JA, Simpson AL, Geevarghese SK, Kingham TP, Jarnagin WR, Miga MI.

J Med Imaging (Bellingham). 2018 Apr;5(2):021203. doi: 10.1117/1.JMI.5.2.021203. Epub 2017 Dec 14.

39.

An academic career in global surgery: a position paper from the Society of University Surgeons Committee on Academic Global Surgery.

Krishnaswami S, Stephens CQ, Yang GP, Nwomeh BC, Swaroop M, Nadler EP, Holterman AX, Simeone DM, Kingham TP, Merchant N, Orloff SL.

Surgery. 2018 Apr;163(4):954-960. doi: 10.1016/j.surg.2017.10.019. Epub 2017 Dec 15. Review.

PMID:
29254606
40.

Health-Seeking Behavior and Barriers to Care in Patients With Rectal Bleeding in Nigeria.

Alatise OI, Fischer SE, Ayandipo OO, Omisore AG, Olatoke SA, Kingham TP.

J Glob Oncol. 2017 Dec;3(6):749-756. doi: 10.1200/JGO.2016.006601. Epub 2017 Feb 1.

41.

Can physician gestalt predict survival in patients with resectable pancreatic adenocarcinoma?

Pak LM, Gonen M, Seier K, Balachandran VP, D'Angelica MI, Jarnagin WR, Kingham TP, Allen PJ, Do RKG, Simpson AL.

Abdom Radiol (NY). 2018 Aug;43(8):2113-2118. doi: 10.1007/s00261-017-1407-x.

42.

Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.

Pak LM, Kemeny NE, Capanu M, Chou JF, Boucher T, Cercek A, Balachandran VP, Kingham TP, Allen PJ, DeMatteo RP, Jarnagin WR, D'Angelica MI.

J Surg Oncol. 2018 Mar;117(4):634-643. doi: 10.1002/jso.24898. Epub 2017 Nov 22.

43.

Developing a Breast Cancer Screening Program in Nigeria: Evaluating Current Practices, Perceptions, and Possible Barriers.

Olasehinde O, Boutin-Foster C, Alatise OI, Adisa AO, Lawal OO, Akinkuolie AA, Adesunkanmi AK, Arije OO, Kingham TP.

J Glob Oncol. 2017 Jan 25;3(5):490-496. doi: 10.1200/JGO.2016.007641. eCollection 2017 Oct.

44.

The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.

Pak LM, Schattner MA, Balachandran V, D'Angelica MI, DeMatteo RP, Kingham TP, Jarnagin WR, Allen PJ.

HPB (Oxford). 2018 Feb;20(2):182-187. doi: 10.1016/j.hpb.2017.09.001. Epub 2017 Oct 9.

45.

3D image guidance assisted identification of colorectal cancer liver metastases not seen on intraoperative ultrasound: results from a prospective trial.

Kingham TP, Pak LM, Simpson AL, Leung U, Doussot A, D'Angelica MI, DeMatteo RP, Allen PJ, Jarnagin WR.

HPB (Oxford). 2018 Mar;20(3):260-267. doi: 10.1016/j.hpb.2017.08.035. Epub 2017 Sep 19.

46.

Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma.

Zheng J, Seier K, Gonen M, Balachandran VP, Kingham TP, D'Angelica MI, Allen PJ, Jarnagin WR, DeMatteo RP.

Ann Surg Oncol. 2017 Nov;24(12):3706-3714. doi: 10.1245/s10434-017-6060-7. Epub 2017 Aug 24.

PMID:
28840521
47.

Deformation correction for image guided liver surgery: An intraoperative fidelity assessment.

Clements LW, Collins JA, Weis JA, Simpson AL, Kingham TP, Jarnagin WR, Miga MI.

Surgery. 2017 Sep;162(3):537-547. doi: 10.1016/j.surg.2017.04.020. Epub 2017 Jul 10.

48.

Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ.

Ann Surg. 2018 Aug;268(2):340-347. doi: 10.1097/SLA.0000000000002421.

49.

Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase.

Zheng J, Glezerman IG, Sadot E, McNeil A, Zarama C, Gönen M, Creasy J, Pak LM, Balachandran VP, D'Angelica MI, Allen PJ, DeMatteo RP, Kingham TP, Jarnagin WR, Jaimes EA.

J Am Coll Surg. 2017 Oct;225(4):488-497.e2. doi: 10.1016/j.jamcollsurg.2017.06.012. Epub 2017 Jul 6.

50.

Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.

Olthof PB, Wiggers JK, Groot Koerkamp B, Coelen RJ, Allen PJ, Besselink MG, Busch OR, D'Angelica MI, DeMatteo RP, Kingham TP, van Lienden KP, Jarnagin WR, van Gulik TM.

J Am Coll Surg. 2017 Sep;225(3):387-394. doi: 10.1016/j.jamcollsurg.2017.06.007. Epub 2017 Jul 4. Erratum in: J Am Coll Surg. 2018 May;226(5):945.

PMID:
28687509

Supplemental Content

Loading ...
Support Center